Anika Therapeutics
ANIK
#8513
Rank
HK$2.19 B
Marketcap
HK$164.34
Share price
-3.85%
Change (1 day)
116.23%
Change (1 year)
Categories

EPS for Anika Therapeutics (ANIK)

EPS in 2026 (TTM): -HK$2.03

According to Anika Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$2.04. In 2025 the company made an earnings per share (EPS) of -HK$5.96 an increase over its 2024 EPS that were of -HK$30.20.

EPS history for Anika Therapeutics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$2.03-65.96%
2025-HK$5.96-80.26%
2024-HK$30.20-31.86%
2023-HK$44.32448.54%
2022-HK$8.08-455.17%
2021HK$2.27-115.68%
2020-HK$14.51-195.85%
2019HK$15.1448.46%
2018HK$10.20-40.37%
2017HK$17.10-1.8%
2016HK$17.417.77%
2015HK$16.16-21.37%
2014HK$20.5574.67%
2013HK$11.7770.45%
2012HK$6.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.51-3,459.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
HK$32.00-1,669.23%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Stryker Corporation
SYK
HK$76.32-3,842.31%๐Ÿ‡บ๐Ÿ‡ธ USA
STAAR Surgical
STAA
HK$0.55-126.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
HK$27.61-1,453.85%๐Ÿ‡บ๐Ÿ‡ธ USA